Autologous Fat Grafting Market Size, Share, and Trends 2026 to 2035

Autologous Fat Grafting Market (By Product Type: Fat Harvesting & Aspiration Systems, Fat Processing/Purification Systems, Integrated Fat Transfer Systems, Accessories & Consumables (Cannulas, Tubing); By Application: Breast Augmentation & Reconstruction, Facial Fat Grafting/Rejuvenation, Buttock Augmentation (BBL), Hand Rejuvenation & Others; By End-User: Hospitals, Clinics & Plastic Surgery Centers, Medical Spas) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 24 Feb 2026  |  Report Code : 7846  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Autologous Fat Grafting Market 

5.1. COVID-19 Landscape: Autologous Fat Grafting Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Autologous Fat Grafting Market, By Product Type

8.1. Autologous Fat Grafting Market Revenue and Volume, by Product Type

8.1.1 Fat Harvesting & Aspiration Systems 

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Fat Processing/Purification Systems 

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Integrated Fat Transfer Systems 

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Accessories & Consumables (Cannulas, Tubing)

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Autologous Fat Grafting Market, By Application

9.1. Autologous Fat Grafting Market Revenue and Volume, by Application

9.1.1. Breast Augmentation & Reconstruction 

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Facial Fat Grafting/Rejuvenation 

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Buttock Augmentation (BBL) 

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Hand Rejuvenation & Others

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Autologous Fat Grafting Market, By End-User

10.1. Autologous Fat Grafting Market Revenue and Volume, by End-User

10.1.1. Hospitals            

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Clinics & Plastic Surgery Centers 

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Medical Spas  

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Autologous Fat Grafting Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type

11.1.2. Market Revenue and Volume Forecast, by Application

11.1.3. Market Revenue and Volume Forecast, by End-User

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type

11.1.4.2. Market Revenue and Volume Forecast, by Application

11.1.4.3. Market Revenue and Volume Forecast, by End-User

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type

11.1.5.2. Market Revenue and Volume Forecast, by Application

11.1.5.3. Market Revenue and Volume Forecast, by End-User

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type

11.2.2. Market Revenue and Volume Forecast, by Application

11.2.3. Market Revenue and Volume Forecast, by End-User

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type

11.2.4.2. Market Revenue and Volume Forecast, by Application

11.2.4.3. Market Revenue and Volume Forecast, by End-User

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type

11.2.5.2. Market Revenue and Volume Forecast, by Application

11.2.5.3. Market Revenue and Volume Forecast, by End-User

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type

11.2.6.2. Market Revenue and Volume Forecast, by Application

11.2.6.3. Market Revenue and Volume Forecast, by End-User

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type

11.2.7.2. Market Revenue and Volume Forecast, by Application

11.2.7.3. Market Revenue and Volume Forecast, by End-User

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type

11.3.2. Market Revenue and Volume Forecast, by Application

11.3.3. Market Revenue and Volume Forecast, by End-User

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type

11.3.4.2. Market Revenue and Volume Forecast, by Application

11.3.4.3. Market Revenue and Volume Forecast, by End-User

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type

11.3.5.2. Market Revenue and Volume Forecast, by Application

11.3.5.3. Market Revenue and Volume Forecast, by End-User

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type

11.3.6.2. Market Revenue and Volume Forecast, by Application

11.3.6.3. Market Revenue and Volume Forecast, by End-User

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type

11.3.7.2. Market Revenue and Volume Forecast, by Application

11.3.7.3. Market Revenue and Volume Forecast, by End-User

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.2. Market Revenue and Volume Forecast, by Application

11.4.3. Market Revenue and Volume Forecast, by End-User

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.4.2. Market Revenue and Volume Forecast, by Application

11.4.4.3. Market Revenue and Volume Forecast, by End-User

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type

11.4.5.2. Market Revenue and Volume Forecast, by Application

11.4.5.3. Market Revenue and Volume Forecast, by End-User

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type

11.4.6.2. Market Revenue and Volume Forecast, by Application

11.4.6.3. Market Revenue and Volume Forecast, by End-User

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type

11.4.7.2. Market Revenue and Volume Forecast, by Application

11.4.7.3. Market Revenue and Volume Forecast, by End-User

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.2. Market Revenue and Volume Forecast, by Application

11.5.3. Market Revenue and Volume Forecast, by End-User

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type

11.5.4.2. Market Revenue and Volume Forecast, by Application

11.5.4.3. Market Revenue and Volume Forecast, by End-User

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.5.2. Market Revenue and Volume Forecast, by Application

11.5.5.3. Market Revenue and Volume Forecast, by End-User

Chapter 12. Company Profiles

12.1. Suneva Medical, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Sisram Medical Ltd (Alma Lasers)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Human Med AG

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. AbbVie Inc. (Allergan Aesthetics)

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Lipogems International S.p.A.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. MicroAire Surgical Instruments

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Ranfac Corp.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Medikan International Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Black Tie Medical

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. MTF Biologics

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The autologous fat grafting market size is expected to increase from USD 226.25 million in 2025 to USD 476.83 million by 2035.

Answer : The autologous fat grafting market is expected to grow at a compound annual growth rate (CAGR) of around 7.74% from 2026 to 2035.

Answer : The major players in the autologous fat grafting market include AbbVie Inc. (Allergan Aesthetics), Sisram Medical Ltd (Alma Lasers), Integra LifeSciences, Bausch Health Companies (Solta Medical), Suneva Medical, Inc., Cytori Therapeutics (Plus Therapeutics), Lipogems International S.p.A., Human Med AG, MicroAire Surgical Instruments, Tulip Medical Products, Ranfac Corp., Medikan International Inc., Black Tie Medical, MTF Biologics, and Genesis Biosystems

Answer : The driving factors of the autologous fat grafting market is fueled by a global shift toward "natural" aesthetics and regenerative medicine, where patients prefer their own biological tissue over synthetic fillers.

Answer : North America region will lead the global autologous fat grafting market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client